Press release
Leading Growth Driver in the Pharmacogenomics Market in 2025: Precision Medicine's Surge And Its Impact On The Growing Pharmacogenomics Market Driver's Influence
Pharmacogenomics
The uptick in precision medicine's necessity is bolstering the pharmacogenomics market's demand. Precision medicine is a healthcare model that advocates for customized care, wherein medical procedures, treatments, and products are bespoke to patient subsets instead of a one-size-fits-all approach. Precision medicine's demand is surging, particularly given its advancements in oncology, and its potential for broader applications beyond oncology, extending to late-stage diseases like rare or genetic diseases. Precision medicine's primary objective is to incorporate genetic and environmental information about certain diseases and their responses to specific treatments. For example, a Linchpinseo article from March 2022 revealed that the rising precision medicine investment demand from top pharmaceutical firms is expected to see a 1/3 surge in the coming five years. Moreover, in the US, precision medicine is aiding 30 million individuals diagnosed and treated for type 2 diabetes by offering customized treatments and adjusting current treatment practices. Therefore, the escalation in precision medicine demand is set to propel the pharmacogenomics market.
Get Your Pharmacogenomics Market Report Here:
https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report
How will the growth rate of the pharmacogenomics market shape industry trends by 2034?
The size of the pharmacogenomics market has witnessed a swift expansion over the past few years. It is expected to inflate from $8.94 billion in 2024 to $9.92 billion in 2025, recording a compound annual growth rate (CAGR) of 10.9%. Factors such as the robust economic development in developing markets, the escalating concentration on precision medicine, the emergence of advanced healthcare infrastructure, and increased healthcare spending have contributed to its growth during the historical period.
The market size for pharmacogenomics is anticipated to experience a significant increase in the coming years, predicted to become a $14.81 billion industry by 2029 with a compound annual growth rate (CAGR) of 10.5%. This expansion during the forecast period is linked to factors such as an aging population, rise in chronic illnesses, population growth, and the heightened demand for cancer treatments. Key trends during this period include the debut of a genome-editing solution for in-depth analysis of advanced treatments, the emphasis on integrating artificial intelligence (AI) within genomics for genetic data analysis, advancements in metagenomics, strategic alliances and teamwork amongst market competitors, the introduction of three-dimensional (3D) genomics for studying the impact on gene expression and functionality, innovative new products centering on infectious diseases and gene editing, and the formulation of psychotropic pharmacogenomics tests for making informed decisions.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7072&type=smp
How are the latest trends influencing the growth of the pharmacogenomics market?
Technological progress is increasingly prominent in the pharmacogenomics market, with drug makers putting a strong emphasis on different pharmacogenomics analysis methods to offer cost-efficient solutions for recognizing known polymorphisms and identifying new variants. For example, in May 2022, the American medical laboratory company, Invitae, introduced an extended version of its Pharmacogenomics Panel. The expanded Invitae Pharmacogenomics (PGx) Panel, inclusive of the Mental Health Panel, provides valuable information about genetic reactions to drugs across different fields such as primary care, cardiology, and oncology. Considering that nearly a quarter of patients experience unusual drug reactions due to their genetics, it is expected that PGx testing will become a routine procedure. In order for this to be successfully incorporated into healthcare, there needs to be improved assistance for providers to comprehend and implement PGx testing within their clinical environments.
Which primary segments of the pharmacogenomics market are driving growth and industry transformations?
The pharmacogenomics market covered in this report is segmented -
1) By Technology: Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies
2) By Application: Neurological Diseases, Infectious Diseases, Oncology, Cardiovascular Diseases, Pain Management, Other Applications
3) By End User: Hospitals and Clinics, Research Institutions, Academic Institutes, Other End Users
Subsegments:
1) By Next Generation Sequencing (NGS): Whole Genome Sequencing, Targeted Sequencing, Exome Sequencing
2) By Polymerase Chain Reaction (PCR): Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR
3) By Gel Electrophoresis: Agarose Gel Electrophoresis, Polyacrylamide Gel Electrophoresis, Capillary Gel Electrophoresis
4) By Mass Spectrometry: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight), HRMS (High-Resolution Mass Spectrometry)
5) By Microarray: SNP Microarrays, Expression Microarrays, Comparative Genomic Hybridization (CGH) Arrays
6) By Other Technologies: Sanger Sequencing, CRISPR-Based Technologies, Bioinformatics Tools
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7072
Which geographical regions are pioneering growth in the pharmacogenomics market?
North America was the largest region in the pharmacogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the pharmacogenomics market landscape?
Major companies operating in the pharmacogenomics market include Illumina Inc, Eurofins Scientific, Myriad Genetics Inc, PerkinElmer Inc, Centogene N.V, Invitae Corporation, Genomind, Pacific Biosciences of California Inc, Oneome LLC, Admera Health, MapMyGenome, Positive Bioscience, Xcode Life Sciences, Xcelris Labs, Takeda Pharmaceutical Company Limited, Garvan Institute of Medical Research, 3D Medicines Inc, Berry Genomics, BGI, GenomiCare Biotechnology, Bayer AG, GlaxoSmithKline plc (GSK), F Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V, Centro de Genoma e Biologia de Sistemas (CGBS), Dasa Group, Datar Cancer Genetics Limited, MedGenome Labs, 23andMe, Color Genomics, Pathway Genomics, Laboratório Richet, Laboratório Exame, Genomika Diagnósticos
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7072&type=smp
What Is Covered In The Pharmacogenomics Global Market Report?
• Market Size Forecast: Examine the pharmacogenomics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the pharmacogenomics market for a structured understanding.
• Key Players Overview: Analyze major players in the pharmacogenomics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pharmacogenomics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the pharmacogenomics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pharmacogenomics market.
• Industry Challenges: Identify potential risks and obstacles affecting the pharmacogenomics market.
• Competitive Landscape: Review strategic developments in the pharmacogenomics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Pharmacogenomics Market in 2025: Precision Medicine's Surge And Its Impact On The Growing Pharmacogenomics Market Driver's Influence here
News-ID: 3902007 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
